Sanofi Dupixent gets USFDA nod for atopic dermatitis

Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood

Tetra Bio-Pharma opens new subsidiary in Australia

The new subsidiary follows the recent announcement of Tetra's partnership with Cannvalate Pty Ltd for the performance of clinical trials of Tetra's drug candidates in Australia.

ANI Pharmaceuticals consolidates operation post Novitium acquisition

Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023

AstraZeneca’s Pascal Soriot awarded British knighthood for services to UK

AstraZeneca also played a critical role in the global response to COVID-19.

Organon introduces global ESG strategy

Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health

David Kendall named Zealand Pharma CMO

Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy

Gilead Sciences appoints Stacey Ma as EVP, Pharmaceutical Development and Manufacturing

Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead

GSK to form consumer healthcare business ‘Haleon’

The proposed demerger is the most significant corporate change for GSK in the last 20 years

Evonik to build new lipid production facility for mRNA-based therapies in U.S.

Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025

Ovensa and Celanese to collaborate to advance precision drug delivery